secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aurinia Pharmaceuticals Inc. (AUPH)
CIK:        0001600620
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001600620-25-000057
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aurinia shareholders approve amended equity plan, elect directors at 2025 AGM
-----------------------------------------------------------------------------

- Shareholders approved amended Equity Incentive Plan (20,836,773 Plan Shares) at May 15, 2025 AGM.
- All six director nominees elected: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Peter Greenleaf, Craig Johnson, Tina Nova.
- Shareholders ratified PwC as auditor (88.3M for, 5.5M against) and approved say-on-pay (58.9M for, 17.2M against).
- Bylaw amendment effective May 15, 2025 gives shareholders right to set the number of directors.
- Plan imposes minimum one-year vesting; up to 5% of Plan Shares may be granted with shorter vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1600620/000160062025000057/0001600620-25-000057-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1600620/000160062025000057/auph-20250515.htm
  HTML page:      https://secwatch.observer/filing/0001600620-25-000057

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer